3 Best Stocks to Buy Now, 8/19/2025, According to Top Analysts

Wall Street's sharpest minds just dropped their hottest picks—and these three names keep surfacing as must-own assets before Q4 kicks in.

Analysts See 30%+ Upside in Tech Titan

One legacy tech player's quietly stacking next-gen AI contracts while the market snoozes on outdated valuation models. Street consensus puts this one at 30% upside minimum—institutional accumulation patterns back the hype.

Healthcare Disruptor Nearing Breakout

FDA catalysts pending, this biotech's pipeline could flip sector dynamics overnight. Top firms are revising targets upward ahead of Phase III data drops—smart money's already positioning.

Energy Play With Dividend Armor

While renewables hog headlines, this old-school energy stock's printing cash with a 5% yield that actually gets paid. Because sometimes the best innovation is a dividend that doesn't get cut.

Timing beats guessing—and these picks come from analysts who actually track institutional flows, not just echo Bloomberg terminals. Their track records suggest getting in before the herd catches on.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Wix.com Ltd. (WIX) – This is an Israeli software company that provides a cloud-based web development platform, enabling users to create HTML5 websites and mobile sitesYesterday, Citizens JMP analyst Andrew Boone maintained a Buy rating on the stock and increased the price target to $200 from $160 per share. Interestingly, 15 out of the 17 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 57.28%. 

Datadog (DDOG) – Datadog is a cloud platform that helps businesses watch and track their apps, servers, and data in real time. YesterdayCiti analyst Fatima Boolani maintained a Buy rating on the stock and increased the price target to $170 from $165 per share. Interestingly, 25 out of the 29 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 25.19%. 

Contineum Therapeutics (CTNM) – This is a clinical-stage biotech company developing oral therapies for neurological, inflammatory, and immune-related diseases. Yesterday, Morgan Stanley analyst Sean Laaman maintained a Buy rating on the stock and increased the price target to $21 from $20 per share. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 171.6%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure